Displaying items 25-36 of 104
» View wsbt.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
•
Next >
-
Novartis names Harry Kirsch new CFO
ReutersZURICH, April 24 (Reuters) - Swiss drugmaker Novartis named Harry Kirsch as new Chief Financial Officer to help improve productivity as the Basel-based drugmaker looks to grow beyond a wave of patent expiries. Novartis said 48-year-old Kirsch, who joined...Tags: Diovan (drug), Alcoholic Beverages, Patents, Copyrights and Trademarks, High Blood Pressure, Corporate Officers
-
PRESS DIGEST-New York Times business news - April 24
ReutersApril 24 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * On Tuesday, Apple Inc announced that it planned to more than double its...Tags: Buyback, The New York Times, Justice System, Crime, Law and Justice, Air Transportation Industry
-
Novartis busca mejoras en la productividad con nuevo director financiero
ReutersZURICH, 24 abr (Reuters) - Novartis promovió a Harry Kirsch, quien ha impulsado mejoras en la productividad en su división de productos farmacéuticos, para ser su director financiero en momentos en que la farmacéutica suiza busca crecer más allá...Tags: Diovan (drug)
-
The day ahead in business April 24
Reports: MBA mortgage index for week ended April 20, 6 a.m.; Durable goods orders for March, 7:30 a.m.; Crude inventories for week ended April 20, 9:30 a.m. Local earnings: Boeing Co., First Midwest Bancorp Inc., Horace Mann Educators Corp., Morningstar...
Tags: Standard Parking Corporation, Boeing Co., Qualcomm Inc., Equifax Incorporated, First Midwest Bancorp Incorporated
-
European shares gain on earnings boost, ECB easing hopes
Reuters* FTSEurofirst up 1.3 percent, Euro STOXX 50 up 1.5 percent * ARM and Richemont beat expected earnings * Mixed PMIs leave space for rate cut * Defensives continue to outperform By Alistair Smout LONDON, April 23 (Reuters) - European shares rose on...Tags: Earnings, Auto Trends, STMicroelectronics NV, European Central Bank, DAX
-
Moody's sees pick-up in pharmaceutical industry M&A in 2013
ReutersLONDON, April 23 (Reuters) - Cash-rich drug companies are likely to make more acquisitions in 2013 after a thin year for deals in 2012, ratings agency Moody's Investors Service said on Tuesday. In an review of the global sector reiterating a "stable"...Tags: AstraZeneca Plc, Bristol Myers Squibb Company, Moody's Corporation
-
INTERVIEW-South Africa seeks to close drug patent loophole
ReutersBy Wendell Roelf CAPE TOWN, April 22 (Reuters) - South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior...Tags: Africa, India, Pharmaceuticals, Drugs and Medicines, Chemical Industry
-
Kareem Abdul-Jabbar continues to promote a healthy, active lifestyle
Over the weekend, Hall of Fame center Kareem Abdul-Jabbar led a processional on a one-mile walk outside of the Georgia Dome in Atlanta. Abdul-Jabbar's Final Four Dome Dribble Fueled by Powerade was part of his campaign to encourage fun, healthy and...Tags: Jimmy Kimmel, National Basketball Association, Lymphoma, Los Angeles Lakers, Kobe Bryant
-
Indian court ruling hailed as victory for generic drugs
The Indian Supreme Court ruled Monday that a Swiss drug company cannot patent a medicine used to treat a rare form of leukemia, in a decision with global implications for generic drugs. The court ruled that Glivec, the drug developed by Novartis, was...
Tags: India, Trade Dispute, Drugs and Medicines, Economic Organization, Contracts
-
Drug maker Novartis loses India patent battle
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions...
Tags: India, Crime, Law and Justice, Pharmaceuticals, HIV Treatment, Chemical Industry
-
10 Things to Know for Today
Your daily look at late-breaking news, upcoming events and the stories that will be talked about today: 1. TEXAS DA'S DEATH PUTS PROSECUTORS ON ALERT Law enforcement is beefing up security for Texas district attorneys after Mike McLelland and his wife...Tags: James Holmes
-
An insider's view of generic-drug pricing
Bob Toomajian worked for 16 years as Kaiser Permanente's drug purchasing manager for Southern California, giving him an insider's knowledge of how medications are priced before reaching consumers. When it comes to patented name-brand drugs, he told me,...
Tags: Prescription Drugs, Pharmaceuticals, Diovan (drug), Drug Trafficking, Lipitor (drug)
Apr 23, 2013
|Story| Reuters
Apr 23, 2013
|Story| Reuters
Apr 24, 2013
|Story| Reuters
Apr 24, 2013
|Story| Chicago Tribune
Apr 23, 2013
|Story| Reuters
Apr 22, 2013
|Story| Reuters
Apr 22, 2013
|Story| Reuters
Apr 12, 2013
|Story| Los Angeles Times
Apr 1, 2013
|Story| Los Angeles Times
Mar 31, 2013
|Story| Los Angeles Times
Apr 1, 2013
|Story| Aberdeen News
Mar 25, 2013
|Column| Los Angeles Times
Original site for Novartis AG topic gallery.